Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical Study to Evaluate the Safety and Tolerability of a Monovalent Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP) in Healthy Adults Aged 18 to 50 Years

NCT06417853 is registered in ClinicalTrials.gov with Vaxxas Pty Ltd as lead sponsor.

NCT NCT06417853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06417853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical Study to Evaluate the Safety and Tolerability of a Monovalent Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP) in Healthy Adults Aged 18 to 50 Years
Lead sponsor
Vaxxas Pty Ltd
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2024
Completion date
January 30, 2026
Enrollment
267 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

h7n9 influenza